Literature DB >> 1937083

Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

H Klaus1, P K Lommatzsch, U Fuchs.   

Abstract

Choroidal malignant melanomas were examined after unsuccessful brachytherapy with 106Ru/106Rh ophthalmic plaques. The histologic findings were compared with those obtained in non-irradiated melanomas similar in size and location. Both groups revealed no significant clinical difference apart from the lower average age of the irradiated patients. Some of the histologic features (scar formation, changes in the distribution of cell types, rate of mitosis) represented reactions to irradiation. No single histologic feature was strongly correlated to the irradiated group. The phenomenon of radioinsensitivity observed in some malignant melanomas cannot be fully elucidated using conventional histologic methods.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937083     DOI: 10.1007/bf00166314

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  34 in total

1.  Radiotherapeutic management of malignant melanoma of the eye.

Authors:  G Ehlers; F Batley; M Kartha
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-03

2.  Focal ionizing radiation of the posterior ocular segment.

Authors:  F W NEWELL; O CHOI; N A BOOK; P V HARPER; A SIMKUS
Journal:  Am J Ophthalmol       Date:  1960-12       Impact factor: 5.258

3.  Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques.

Authors:  U Fuchs; T Kivelä; A Tarkkanen; L Laatikainen
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-06

4.  Proton irradiation therapy for ocular melanoma.

Authors:  I J Constable
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

5.  Histopathology of uveal melanomas treated with charged particle radiation.

Authors:  J B Crawford; D H Char
Journal:  Ophthalmology       Date:  1987-06       Impact factor: 12.079

6.  Failure of choroidal melanoma to respond to helium ion therapy.

Authors:  D H Char; J B Crawford; J R Castro; K H Woodruff
Journal:  Arch Ophthalmol       Date:  1983-02

7.  Lymphocytic infiltration in choroidal melanoma and its prognostic significance.

Authors:  F H Davidorf; J R Lang
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

8.  Malignant melanoma of the choroid: treatment with episcleral 198Au plaque and xenon-arc photocoagulation.

Authors:  R A Moura; A R McPherson; J Easley
Journal:  Ann Ophthalmol       Date:  1985-02

9.  Helium ion therapy for choroidal melanoma.

Authors:  D H Char; W Saunders; J R Castro; J M Quivey; A R Irvine; R D Stone; J B Crawford; M Barricks; L I Lonn; G F Hilton
Journal:  Ophthalmology       Date:  1983-10       Impact factor: 12.079

10.  Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors.

Authors:  J M Seddon; L Polivogianis; C C Hsieh; D M Albert; J W Gamel; E S Gragoudas
Journal:  Arch Ophthalmol       Date:  1987-06
View more
  3 in total

1.  18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.

Authors:  R van Ginderdeuren; E van Limbergen; W Spileers
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

2.  [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].

Authors:  L M Heindl; M Lotter; V Strnad; R Sauer; G O H Naumann; H L J Knorr
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

3.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.